qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

The screening—known as a liquid biopsy—is being rolled out to around 15,000 patients with suspected lung cancer, NHS England ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

As a lung cancer advocate from Maine whose family has been impacted by this terrible disease, I am deeply concerned about the ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

Announcing the rollout on the eve of the world’s largest cancer conference, which will take place in Chicago from Friday, NHS ...

Christopher Danes, PhD, discusses a study exploring the differences in priorities for patients and their caregivers when undergoing treatment for non–small cell lung cancer.

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people ...